Factors Associated with Lower Respiratory Tract Infections in HIV-Exposed Uninfected Infants

AIDS Res Hum Retroviruses. 2018 Jun;34(6):527-535. doi: 10.1089/AID.2017.0245. Epub 2018 Apr 23.

Abstract

To identify factors that predispose human immunodeficiency virus (HIV)-exposed uninfected infants (HEUs) to higher incidence of severe infections, hospitalization, and death in the first 6-24 months of life compared with HEUs with and without lower respiratory tract infection (LRTI) in the first 6 months of life. Nested case-control study of 107 LRTI+ infants enrolled in the International Site Development Initiative (NISDI) Perinatal and Longitudinal Study in Latin American Countries (LILAC) studies with and 140 LRTI- in the first 6 months, matched by date and place of birth. Infants and mothers had plasma antibodies measured against respiratory syncytial virus (RSV), parainfluenza (PIV) 1, 2, 3, influenza, and pneumococcus 1, 5, 6B, and 14. Compared with LRTI-, mothers of LRTI+ HEUs had lower years of education, lower CD4+ cells, and higher HIV plasma viral load at delivery, but similar use of antiretrovirals and cotrimoxazole and other sociodemographic characteristics. LRTI+ and LRTI- HEUs had similar demographic and hematological characteristics and antibody concentrations against respiratory pathogens at birth. At 6 months, the rates of seroconversions to respiratory pathogens and antibody responses to tetanus vaccine were also similar. However, antibody concentrations to RSV were significantly higher in LRTI+ compared with LRTI- HEUs and marginally higher to PIV1. Maternal factors associated with advanced HIV disease, but unrelated to the use of antiretrovirals, cotrimoxazole, or the level of maternal antibodies against respiratory pathogens, contribute to the increased risk of LRTI in HEUs. In HEUs, antiretroviral and cotrimoxazole use, exposure to respiratory pathogens and humoral immune responses were not associated with the incidence of LRTI.

Keywords: HIV infection; HIV-exposed infants; respiratory infection; respiratory syncytial virus; tetanus vaccine.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Adult
  • Case-Control Studies
  • Environmental Exposure*
  • Female
  • HIV Infections*
  • Hospitalization
  • Humans
  • Incidence
  • Infant
  • Infant, Newborn
  • Latin America / epidemiology
  • Male
  • Pneumococcal Infections / epidemiology*
  • Pregnancy
  • Respiratory Tract Infections / epidemiology*
  • Risk Factors
  • Survival Analysis
  • Virus Diseases / epidemiology*
  • Young Adult